Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Serious after-effects no more likely after a third COVID-19 vaccine

    Publicly released: Fri 15 Apr 2022 at 0100 AEST | 0300 NZST

    JAMA Network Open

    Researchers delved into electronic health records from 48,000 Americans, finding people who had three Pfizer or Moderna vaccine shots (using the same vaccine) weren’t more likely to report serious Read more about Serious after-effects no more likely after a third COVID-19 vaccine

    Internationalnference (a company that collaborates with health organisations on data science initiatives), Mayo Clinics in various states including Minnesota, Florida, Arizona (US)
  2. If you're at risk of developing heart problems, you may be at risk of more severe COVID-19

    Publicly released: Thu 14 Apr 2022 at 0801 AEST | 1001 NZST

    European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

    6 per 1000 in the low-risk group. Hospitalisation and ICU rates were also substantially higher, they say. ... fund an Intermediate Clinical Fellowship for Charlotte Warren-Gash and the British Heart Read more about If you're at risk of developing heart problems, you may be at risk of more severe COVID-19

    InternationalLondon School of Hygiene &Tropical Medicine, UK
  3. How effective has the fourth COVID-19 vaccine dose been in Israel?

    Publicly released: Thu 14 Apr 2022 at 0700 AEST | 0900 NZST

    New England Journal of Medicine

    A fourth dose of a COVID-19 vaccine can reduce the risk of severe disease in the short term, according to Israeli research. ... The team used hospital data to examine the difference in COVID-19 outcomes Read more about How effective has the fourth COVID-19 vaccine dose been in Israel?

    InternationalClalit Research Institute, Israel
  4. What household cleaning products can inactivate SARS-CoV-2?

    Publicly released: Tue 12 Apr 2022 at 1500 AEST | 1700 NZST

    Viruses

    over the potential SARS-CoV-2 contaminated surface and allowing it to dry,” Dr McAuley said. ... The study also tested whether combining the household products would increase their effectiveness and Read more about What household cleaning products can inactivate SARS-CoV-2?

    Australia; VICThe Peter Doherty Institute for Infection and Immunity...
  5. Risk of heart inflammation from COVID-19 vax lower than from Influenza vax

    Publicly released: Tue 12 Apr 2022 at 0830 AEST | 1030 NZST

    The Lancet Respiratory Medicine

    1] Myopericarditis is a condition that causes inflammation of the heart muscle and, in some cases, severe permanent heart damage. ... 9 cases per million doses), males (23 cases per million doses), and Read more about Risk of heart inflammation from COVID-19 vax lower than from Influenza vax

    InternationalNational University Hospital, Singapore
  6. Are you physically less likely to become infected with COVID-19?

    Publicly released: Tue 12 Apr 2022 at 0100 AEST | 0300 NZST

    Nature Genetics

    Genetic association studies can help to identify the genes and biological pathways underlying a given physical outcome or trait. ... Using these genetic and survey data, the authors analysed four Read more about Are you physically less likely to become infected with COVID-19?

    InternationalAncestryDNA, USA
  7. Reducing crisis risk in tourism, hospitality

    Publicly released: Mon 11 Apr 2022 at 1200 AEST | 1400 NZST

    Tourism Review International

    This study builds on calls for further investigations into how tourism destinations plan for, and respond to, future global crises and disasters and the roles of political leaders, says first author Read more about Reducing crisis risk in tourism, hospitality

    Australia; New Zealand; VIC; SAFlinders University|University of Canterbury
  8. How frequently do vaccinated cancer patients catch COVID-19?

    Publicly released: Sat 9 Apr 2022 at 0100 AEST | 0300 NZST

    JAMA Oncology

    The team used US electronic health records to find people with the 12 most common cancers who had been vaccinated before any COVID-19 infection and compared breakthrough infection rates through Read more about How frequently do vaccinated cancer patients catch COVID-19?

    InternationalCase Western Reserve University, USA
  9. Vaccine-related blood clots could be the result of genetics

    Publicly released: Fri 8 Apr 2022 at 1102 AEST | 1302 NZST

    medRxiv

    Together, this suggests that it is the combination of a variant in a gene and the evolution of this antibody towards targeting the PF4 protein in a destructive manner, which is ... Tan and Tom Paul Gordon Read more about Vaccine-related blood clots could be the result of genetics

    Australia; SAFlinders University|SA Pathology
  10. Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Publicly released: Fri 8 Apr 2022 at 1100 AEST | 1300 NZST

    PLOS ONE

    Victoria's four-month COVID-19 lockdown in 2020 negatively affected the mental health of the state's residents, according to Aussie researchers, who say this impact was not permanent, and ... The team Read more about Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Australia; VIC; ACTMonash University|The Australian National University
  11. Could a sniff test using smelly stuff at home pick up COVID-19?

    Publicly released: Fri 8 Apr 2022 at 0900 AEST | 1100 NZST

    Communications Medicine

    Researchers have designed an online tool to assess people’s ability to sniff out smelly household items like cumin, basil and vinegar. ... The team says though this wasn’t a clinical study, the tool Read more about Could a sniff test using smelly stuff at home pick up COVID-19?

    InternationalWeizmann Institute of Science, Bezalel Academy of Fine Arts and Design, Edith Wolfson Medical Center, Tel Aviv University (Israel), Karolinska Institutet and Stockholm University (Sweden), University of Oslo (Norway), University of Tokyo (Japan), Champalimaud Centre for the Unknown (Portugal), University of Florence (Italy)
  12. How do Delta and Omicron symptoms differ for vaccinated people?

    Publicly released: Fri 8 Apr 2022 at 0801 AEST | 1001 NZST

    The Lancet

    9% of patients admitted versus 2. 6%). And the duration of acute symptoms was shorter during omicron prevalence than during delta prevalence. ... characteristics of COVID-19 and the dynamics of its Read more about How do Delta and Omicron symptoms differ for vaccinated people?

    InternationalKing’s College London, UK
  13. Motivation - not only attitude - is key when it comes to vaccine decisions

    Publicly released: Fri 8 Apr 2022 at 0400 AEST | 0600 NZST

    PLOS ONE

    Kiwi and Australian researchers sought to understand - and predict - the motivation of individuals to be vaccinated against COVID-19, using a policy response framework. ... They found that willingness Read more about Motivation - not only attitude - is key when it comes to vaccine decisions

    Australia; New Zealand; NSWManaaki Whenua - Landcare Research|The University of New England
  14. At-risk Kiwis show strong immune response to Pfizer vaccine

    Publicly released: Thu 7 Apr 2022 at 1200 AEST | 1400 NZST

    Similar to international data, neutralising responses to the Omicron variant were very low compared to the original strain, on which the Pfizer vaccine is based, and the Delta variant. ... BACKGROUNDKa Read more about At-risk Kiwis show strong immune response to Pfizer vaccine

    New ZealandMalaghan Institute of Medical Research|University of Otago...
  15. Serious blood clot risk for months after getting COVID-19

    Publicly released: Thu 7 Apr 2022 at 0830 AEST | 1030 NZST

    The BMJ

    clot in the lung) up to six months, and a bleeding event up to two months. ... embolism, and an almost twofold increase in risk of bleeding in the 30 days after infection. Read more about Serious blood clot risk for months after getting COVID-19

    InternationalUmeå University (Sweden), The Open University (UK), University of Helsinki and Helsinki University Hospital (Finland)
  16. Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    Publicly released: Thu 7 Apr 2022 at 0100 AEST | 0300 NZST

    JAMA Network Open

    The researchers assessed the combined results of three trials including about 2000 participants, and found there was a 94. ... They say Fluvoxamine could be a more widely accessible option to supplement Read more about Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    InternationalMcGill University Health Centre, Canada
  17. Meddle: the medical Wordle that’s boosting mental health

    Publicly released: Wed 6 Apr 2022 at 1100 AEST | 1300 NZST

    The six-letter, seven-shot word game works much like its counterpart, but uses only medical words, no abbreviations, and no brand names. ... wellbeing. “Amid a pandemic, everyone is struggling. Meddle Read more about Meddle: the medical Wordle that’s boosting mental health

    Australia; SAUniversity of South Australia
  18. Super-spreader events may cement new COVID-19 variants

    Publicly released: Wed 6 Apr 2022 at 0901 AEST | 1101 NZST

    Journal of the Royal Society Interface

    Novel variants have prolonged the COVID-19 pandemic, leading to countless infections and deaths. ... These findings help us to understand past emergence and highlight the importance of preventing Read more about Super-spreader events may cement new COVID-19 variants

    InternationalFred Hutchinson Cancer Research Center, University of Washington, Seattle, US.
  19. Are our kits and puppers giving us superbugs?

    Publicly released: Wed 6 Apr 2022 at 0801 AEST | 1001 NZST

    European Congress of Clinical Microbiology & Infectious Diseases

    The health of companion animals was evaluated by their vet when attending the Small Animal Veterinary Teaching Hospital at the University of Lisbon and the Royal Veterinary College Small Animal Read more about Are our kits and puppers giving us superbugs?

    InternationalUniversity of Lisbon, Portugal
  20. Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    Publicly released: Wed 6 Apr 2022 at 0700 AEST | 0900 NZST

    New England Journal of Medicine

    5 times lower rate of severe COVID-19 illness in the fourth week afterwards than people with a triple dose. ... A fourth vaccine also held up against becoming infected - in the same timeframe, confirmed Read more about Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    InternationalWeizmann Institute of Science, Technion–Israel Institute of Technology, the Hebrew Universityof Jerusalem, Israel Ministry of Health, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Aviv University (all Israel)

Show Results

  1. 10
  2. 20
  3. 50